Swiss National Bank

Bank

Position in HROW — Harrow, Inc.

CIK 1582202 ZURICH, V8

Position in HROW

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$2,189,646

-$853,254 QoQ

Shares Held

62,100

0.0% QoQ

Ownership

0.167%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $531,346,390 across 28 Drug Manufacturers - Specialty & Generic names. HROW ranks #21 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,293,332	$152,884,775
2	TEVA	Teva Pharmaceutical Industries Ltd	4,227,900	$127,344,348
3	UTHR	UNITED THERAPEUTICS Corp	120,055	$71,190,213
4	NBIX	Neurocrine Biosciences Inc	292,600	$38,547,124
5	VTRS	Viatris Inc	2,279,402	$30,794,721
6	ELAN	Elanco Animal Health Inc	983,392	$23,532,570
7	ALKS	Alkermes plc.	310,300	$10,972,208
8	LNTH	Lantheus Holdings, Inc.	131,154	$9,948,030

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,189,646	62,100	0.0%	Shares	Sole	2026-05-07
2025-12-31	$3,042,900	62,100	+3.3%	Shares	Sole	2026-02-12
2025-09-30	$2,895,618	60,100	0.0%	Shares	Sole	2025-11-13
2025-06-30	$1,835,454	60,100	+2.4%	Shares	Sole	2025-08-12
2025-03-31	$1,561,420	58,700	-1.0%	Shares	Sole	2025-05-12
2024-12-31	$1,989,515	59,300	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$2,639,152	58,700	-0.3%	Shares	Sole	2024-11-07
2024-03-31	$779,247	58,900	-5.5%	Shares	Sole	2024-05-07
2023-12-31	$697,760	62,300	-4.7%	Shares	Sole	2024-02-06
2023-09-30	$939,798	65,400	+5.5%	Shares	Sole	2023-11-08
2023-06-30	$1,180,480	62,000	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.